Metastatic non-small cell lung cancer: a benchmark for quality end-of-life cancer care?
Jennifer Philip, Peter Hudson, Adam Bostanci, Annette Street, Dell E Horey, Sanchia Aranda, Rachel Zordan, Bruce D Rumbold, Gaye Moore, Vijaya Sundararajan
MEDICAL JOURNAL OF AUSTRALIA | AUSTRALASIAN MED PUBL CO LTD | Published : 2015
OBJECTIVES: To investigate the quality of end-of-life care for patients with metastatic non-small cell lung cancer (NSCLC). DESIGN AND PARTICIPANTS: Retrospective cohort study of patients from first hospitalisation for metastatic disease until death, using hospital, emergency department and death registration data from Victoria, Australia, between 1 July 2003 and 30 June 2010. MAIN OUTCOME MEASURES: Emergency department and hospital use; aggressiveness of care including intensive care and chemotherapy in last 30 days; palliative and supportive care provision; and place of death. RESULTS: Metastatic NSCLC patients underwent limited aggressive treatment such as intensive care (5%) and chemothe..View full abstract
Our study was supported by a peer-reviewed grant from the Victorian Cancer Agency.